摘要 |
Applicants have discovered that a variety of neurodegenerative diseases can be diagnosed, or screened for, by the analysis of a patient's mitochondrial metabolism, and thereby provide a screening assay for therapeutic drugs for the treatment of such neurodegenerative diseases. |